Tarsons Products Ltd.

₹181.63

1.8 (1%)

TARSONS Share Price

Healthcare Equipment & Supplies

As on April 2, 2026

SectorHealthcare

IndustryHealthcare Equipment & Supplies

Basic IndustryMedical Equipment & Supplies

Market Cap₹ 958 Cr

P/E Ratio32.46

Dividend YieldN/A

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	177.84	Bullish
10-DMA	180.33	Bullish
20-DMA	186.42	Bearish
50-DMA	194.38	Bearish
100-DMA	212.3	Bearish
200-DMA	275.36	Bearish

Historical Performance

1 Year

-50.5%

3 Years

-65.9%

5 Years

N/A

10 Years

N/A

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2022	Mar-2021
Net Sales	3,924	2,964	3,008	2,289
Total Expenditure	2,815	1,965	1,481	1,256
Other Income	160	115	85	56
Operating Profit	1,268	1,113	1,612	1,088
Interest	195	102	42	27
Depreciation	625	404	220	137
Profit Before Tax	448	608	1,350	924
Consolidated Net Profit	298	426	1,007	689
Adjusted EPS	6	8	19	14

Compounded Sales Growth

10 Years:11.4

5 Years:11.4

3 Years:5.5

TTM:5.8

Compounded Profit Growth

10 Years:-15.4

5 Years:-15.4

3 Years:-21.6

TTM:-6.9

Stock Price CAGR

10 Years:N/A

5 Years:N/A

3 Years:-30.6

TTM:-50.4

Return on Equity

10 Years:N/A

5 Years:N/A

3 Years:18.9

last year:5.6

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2022	Mar-2021
Share Capital	106	106	106	2
Total Reserves	6,196	6,022	4,792	2,441
Long-Term Borrowings	---	---	---	---
Total Non-Current Liabilities	2,741	1,462	1,486	1,057
Other Current Liabilities	854	918	195	112
Short Term Borrowings	692	1,022	10	231
Total Liabilities	10,942	9,885	6,734	3,918
Capital Work in Progress	2,329	2,670	322	215
Long Term Loans & Advances	677	1,340	2,078	1,362
Currents Investments	---	---	---	---
Short Term Loans and Advances	235	208	69	98
Total Current Assets	2,567	2,516	2,445	1,128
Total Assets	10,942	9,885	6,734	3,918
Adjusted Book Value	118	115	92	48

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 32.46, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a weak 3-year price CAGR of -30.6%, indicating poor shareholder returns.
The stock carries a beta of 1.0, indicating volatility broadly in line with the market.
In the last financial year, the company reported an EBITDA of ₹1268 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹3924 million, suggesting a mid-sized operation.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 496460.3

No. of Shares: 2733 (Approx)

Performance:-50.4%

P/L: ₹-503539.7

NIFTY Performance: -2.3%

1 day Top Gainers